Trial Profile
Patient reported outcomes with Onabotulinumtoxin-a
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 19 Aug 2015 New trial record
- 21 Jun 2015 Results presented at the 57th Annual Scientific Meeting of the American Headache Society.